[
  {
    "ts": "2024-12-11T13:00:00+00:00",
    "headline": "Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S.",
    "summary": "DEERFIELD, Ill., December 11, 2024--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product launches in the U.S., joining the previous five launches announced in April of this year and marking a total of 10 U.S. injectable product launches in 2024.",
    "url": "https://finance.yahoo.com/news/baxter-announces-continued-growth-pharmaceuticals-130000364.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "4b69056d-cd99-30d6-8e50-c5f90d6d703c",
      "content": {
        "id": "4b69056d-cd99-30d6-8e50-c5f90d6d703c",
        "contentType": "STORY",
        "title": "Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S.",
        "description": "",
        "summary": "DEERFIELD, Ill., December 11, 2024--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product launches in the U.S., joining the previous five launches announced in April of this year and marking a total of 10 U.S. injectable product launches in 2024.",
        "pubDate": "2024-12-11T13:00:00Z",
        "displayTime": "2024-12-11T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/2bc7836fe09e178a8b6a83a29cf0d368",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oSX3ZItKJNJN5Hp4P1RSqw--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/2bc7836fe09e178a8b6a83a29cf0d368.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YCsG6zDsl2dCfkjeu0muUQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2bc7836fe09e178a8b6a83a29cf0d368.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/baxter-announces-continued-growth-pharmaceuticals-130000364.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/baxter-announces-continued-growth-pharmaceuticals-130000364.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]